Scholarlink

Introduction <p>Safety concerns remain an important barrier to pediatric influenza vaccination, yet directly comparable evidence across vaccine platforms, valency formulations, and administration routes remains limited. This study compared the safety profiles of five seasonal influenza vaccines in Chinese children and adolescents.</p> Methods <p>We pooled individual-level safety data from five clinical studies including participants aged 6–17&#xa0;years. Adverse event (AE) incidences and 95% confidence intervals (CIs) were estimated using Clopper–Pearson methods, and multivariable logistic regression models were used to compare AE risks.</p> Results <p>Among 2885 participants, overall AE incidence was 23.1% (95% CI, 21.6–24.7%). Grade 3 AEs were uncommon (≤ 1.1%), and no serious AEs were reported. AE profiles differed across vaccine platforms: inactivated vaccines were mainly associated with pyrexia and injection-site reactions, whereas trivalent live attenuated influenza vaccine was characterized by rhinorrhea, cough, and nasal congestion. Compared with trivalent inactivated split-virion vaccine, quadrivalent inactivated subunit vaccine was associated with lower odds of any AE (aOR, 0.52; 95% CI, 0.35–0.79) and local AEs (aOR, 0.30; 95% CI, 0.17–0.52).</p> Conclusions <p>All five vaccines showed acceptable short-term safety, with platform-specific reactogenicity patterns. Among inactivated vaccines, the quadrivalent subunit formulation showed a relative local tolerability advantage.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical Studies

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月6日

查看全文
  • Le Hu,
  • Yue Liu,
  • Siyue Jia,
  • Mingwei Wei,
  • Pengfei Jin,
  • Feng Wen,
  • Hongxing Pan,
  • Kai Chu,
  • Yanjun Chen,
  • Zijie Zhang,
  • Jingxin Li

摘要

Introduction

Safety concerns remain an important barrier to pediatric influenza vaccination, yet directly comparable evidence across vaccine platforms, valency formulations, and administration routes remains limited. This study compared the safety profiles of five seasonal influenza vaccines in Chinese children and adolescents.

Methods

We pooled individual-level safety data from five clinical studies including participants aged 6–17 years. Adverse event (AE) incidences and 95% confidence intervals (CIs) were estimated using Clopper–Pearson methods, and multivariable logistic regression models were used to compare AE risks.

Results

Among 2885 participants, overall AE incidence was 23.1% (95% CI, 21.6–24.7%). Grade 3 AEs were uncommon (≤ 1.1%), and no serious AEs were reported. AE profiles differed across vaccine platforms: inactivated vaccines were mainly associated with pyrexia and injection-site reactions, whereas trivalent live attenuated influenza vaccine was characterized by rhinorrhea, cough, and nasal congestion. Compared with trivalent inactivated split-virion vaccine, quadrivalent inactivated subunit vaccine was associated with lower odds of any AE (aOR, 0.52; 95% CI, 0.35–0.79) and local AEs (aOR, 0.30; 95% CI, 0.17–0.52).

Conclusions

All five vaccines showed acceptable short-term safety, with platform-specific reactogenicity patterns. Among inactivated vaccines, the quadrivalent subunit formulation showed a relative local tolerability advantage.